<DOC>
	<DOCNO>NCT02848274</DOCNO>
	<brief_summary>The purpose study develop prognostic index model rare disease mycosis fungoides sezary syndrome . This do collecting standardized clinical data various institution . The investigator hope enable identification low- high-risk group survival order improve patient care outcome .</brief_summary>
	<brief_title>ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Mycosis Fungoides</mesh_term>
	<mesh_term>Sezary Syndrome</mesh_term>
	<criteria>Inclusion Criteria Diagnosis advance stage MF SS ( Stages IIB IVB ) within 6 month presentation participate center Patients expect care administer participate center jointly refer physician ( ) followup data would available Exclusion Criteria Patients diagnose early stage MF/SS ( Stages IAIIA ) progress advanced stage Patients diagnose advanced MF/SS 6 month prior initial presentation participate center Exclude onetime consultation type new patient .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>